Hao H, Manfredi G, Moraes C T
Department of Neurology, University of Miami, FL, USA.
Am J Hum Genet. 1997 Jun;60(6):1363-72. doi: 10.1086/515474.
An approximately 260-bp tandem duplication of the human mtDNA regulatory region has been identified in patients with mitochondrial disorders and in a specific Caucasian haplogroup. The functional significance of this mtDNA duplication was difficult to assess, because it was present at very low levels in human tissues. We have isolated several transmitochondrial cybrid lines harboring this mutation, one of which (clone CA17.1) was essentially homoplasmic for the duplication. Oxidative-phosphorylation function was not impaired in clone CA17.1, suggesting that this mtDNA alteration is not pathogenic. mtDNA copy number and steady-state levels of heavy- and light-strand transcripts were unaltered in clone CA 17.1. The steady-state levels of RNAs made from the two promoters (either from the heavy-strand or from the light-strand) were also similar, indicating that oppositely oriented promoters did not interfere with each other.
在患有线粒体疾病的患者以及特定的高加索单倍群中,已发现人类线粒体DNA(mtDNA)调控区域存在约260个碱基对的串联重复。这种mtDNA重复的功能意义难以评估,因为它在人体组织中的含量非常低。我们分离出了几个携带这种突变的线粒体杂交细胞系,其中一个(克隆CA17.1)基本上是该重复序列的同质性细胞系。克隆CA17.1中的氧化磷酸化功能未受损,这表明这种mtDNA改变不具有致病性。克隆CA17.1中的mtDNA拷贝数以及重链和轻链转录本的稳态水平未发生改变。由两个启动子(重链或轻链)产生的RNA的稳态水平也相似,这表明方向相反的启动子不会相互干扰。